Form4insider filings, from the source

SEC Form 4 · accession 0001225208-17-012614

PORTOLA PHARMACEUTICALS INC · PTLA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 16, 2017
Accepted (ET)
Jul 14, 2017 · 7:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 16, 2017A3,000$0.00A6,000D
Common StockF3holding———45,402IBy Ltd Partnership (NEST)
Common StockF4holding———921,610IBy Ltd Partnership (SHV)
Common StockF5holding———59,053IBy Trust (Trustees)

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2,F6$35.06Jun 16, 2017A6,000A—Jun 16, 2027Common Stock6,0006,000D

Explanation of responses